Show simple item record

dc.contributor.authorCarlyle, M
dc.contributor.authorRockliff, H
dc.contributor.authorEdwards, R
dc.contributor.authorEne, C
dc.contributor.authorKarl, A
dc.contributor.authorMarsh, B
dc.contributor.authorHartley, L
dc.contributor.authorMorgan, CJA
dc.date.accessioned2019-10-24T09:34:47Z
dc.date.issued2019-04-02
dc.description.abstractOpioid use disorder (OUD) is reaching epidemic proportions worldwide, and is notoriously difficult to treat. Compassion focused therapy (CFT) has emerged as therapeutic tool for treating individuals exhibiting high levels of self-criticism and low self-esteem, both of which are common in OUD. Until now, however, there had been no research investigating this therapy in patients with OUD. Before running a premature clinical trial, it is important to fully assess the feasibility and acceptability of this treatment in this group of individuals. We aimed to assess the feasibility of CFT treatment in individuals with OUD in a short group intervention, which was co-created by the research team, service users and a local drugs service. The intervention involved three 2-hour sessions held over 3 weeks, where participants engaged in compassion-orientated psychoeducation and self-compassionate exercises. Individuals were randomly assigned to either the CFT group (n = 15), the active control (relaxation) group (n = 12) or the waitlist control group (n = 11). Of 103 individuals approached, 45% attended a baseline visit suggesting the treatment was acceptable to this group. A relatively low attrition rate across the 3 groups was found for CFT (21.1%), with no difference in drop-out between the groups. Qualitative analysis of interviews with participants identified a desire for more sessions. Compassion focused therapy was thus feasible and well-tolerated in those with OUD, and a further trial to evaluate any clinical differences may be warranted.en_GB
dc.description.sponsorshipEconomic and Social Research Council (ESRC)en_GB
dc.identifier.citationVol. 13en_GB
dc.identifier.doi10.1177/1178221819836726
dc.identifier.grantnumberEP/P000630/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/39317
dc.language.isoenen_GB
dc.publisherSAGE Publicationsen_GB
dc.rights© The Author(s)/ Open access. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).en_GB
dc.subjectself-compassionen_GB
dc.subjectopioiden_GB
dc.subjectaddictionen_GB
dc.subjectfeasibilityen_GB
dc.subjectpilot interventionen_GB
dc.subjectcravingen_GB
dc.titleInvestigating the Feasibility of Brief Compassion Focused Therapy in Individuals in Treatment for Opioid Use Disorderen_GB
dc.typeArticleen_GB
dc.date.available2019-10-24T09:34:47Z
dc.descriptionThis is the final version. Available on open access from SAGE Publications via the DOI in this recorden_GB
dc.identifier.eissn1178-2218
dc.identifier.journalSubstance Abuse: Research and Treatmenten_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2018-12-05
exeter.funder::Economic and Social Research Council (ESRC)en_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2019-04-02
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-10-24T09:32:29Z
refterms.versionFCDVoR
refterms.dateFOA2019-10-24T09:34:53Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s)/ Open access. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Except where otherwise noted, this item's licence is described as © The Author(s)/ Open access. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).